DR

Daniel Ramirez

VP Health Care | Venture Capital | Corporate Venture Building | M&A | Innovation

📍 Palo Alto, California, United States🔄 Updated October 2026💼 4 investments📅 9 years investing🗓 Last invested Apr 2025𝕏 @upgrade_to_unlock
VC🌍 United States
4
Total investments
2
Early stage
0
Mid stage
1
Late stage
9y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2025
Kridas AI intelligence layer streamlines commercial lending by automating the repetitive, manual parts of pre-underwriting document collection, lead tracking, and data extraction. Krida reduces cycle times, manual tasks, and borrower drop-off, thereby giving banks and credit unions a faster path to funded loans, higher throughput, and stronger community relationships.
Investor
Jul 2024
Myriad empowers compliance teams by revolutionizing how they access and apply regulations. Our cutting-edge platform ensures you always have the most comprehensive and up-to-date insights at your fingertips, dramatically speeding up decision-making and enhancing business outcomes. Myriads AI-driven agents interpret complex regulations tailored to your specific business needs, delivering precise answers in record time.
Investor and Advisor
Jan 2019
Centaur Labs is the modern data labeling solution for AI innovators across the healthcare landscape. With an expert crowd of 50k+ labelers and a gamified app to incentivize and quality-control them, our scaleable labeling methodology ensures high-quality labels in as little as 24 hours.
Investor, Board Observer and Operating Partner
Feb 2017
Did you know that 1 in 5 people can develop skin cancer during their lifetime? While being one of the most prevalent types of cancer, if caught in time, skin cancer has the highest success rate in treatment and recovery. The timely reaction makes regular and reliable self-skin exams essential. With over 2 million users worldwide, SkinVision provides a medical service that democratizes access to reliable, convenient and accurate detection of risk of the most common types of skin cancer, helping to bring the right people in front of the healthcare practitioner in time for successful treatment. Empowered by a highly accurate AI-based algorithm, our app combines cutting-edge technology with best-in-class dermatologists expertise and support. SkinVision is clinically validated and can detect signs of most common skin cancers with 95% sensitivity. At SkinVision, we are continuously expanding our ecosystem. Together we are focused on taking skin health care to the next level, creating the highest patient-doctor value and eradicating skin cancer mortality worldwide. We are on a mission of saving the lives of 250.000 people in the next decade. If you share our vision and would like to become a SkinVision partner, write to us at partners@skinvision.com. Want to join us on this incredible journey and be a part of our dynamic team, check out our careers page https://skinvision1.recruitee.com/
Experience · 7 entries
All (7)
Investments (4)
Board (1)
2025
Investor
Apr 2025
Kridas AI intelligence layer streamlines commercial lending by automating the repetitive, manual parts of pre-underwriting document collection, lead tracking, and data extraction. Krida reduces cycle times, manual tasks, and borrower drop-off, thereby giving banks and credit unions a faster path to funded loans, higher throughput, and stronger community relationships.
2024
Investor
Jul 2024
Myriad empowers compliance teams by revolutionizing how they access and apply regulations. Our cutting-edge platform ensures you always have the most comprehensive and up-to-date insights at your fingertips, dramatically speeding up decision-making and enhancing business outcomes. Myriads AI-driven agents interpret complex regulations tailored to your specific business needs, delivering precise answers in record time.
2022
Founding Partner
Jan 2022
We invest in brilliant founders building breakthrough technologies that can scale to become transformational platforms.
2019
Investor and Advisor
Jan 2019
Centaur Labs is the modern data labeling solution for AI innovators across the healthcare landscape. With an expert crowd of 50k+ labelers and a gamified app to incentivize and quality-control them, our scaleable labeling methodology ensures high-quality labels in as little as 24 hours.
2018
Vice President Technology Search & Partnering - LEO Innovation lab
Jan 2018
LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. LEO Pharma is headquartered in Denmark with a global team of 4,200 people, serving millions of patients across the world. In 2023, the company generated net sales of DKK 11.4 billion. Disclaimer: This site is intended for discussions about LEO Pharma and the various initiatives LEO Pharma is involved in. Due to regulations, discussions about pharmaceutical products are not allowed on this site. All content must be factual and non-promotional. LEO Pharma reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and LEO Pharma’s values, including: - profane or vulgar language - insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc. - commercial or political advertising - copyright infringements, or any violation of the rights of external parties - automatically-generated content i.e. spam - wrong/false statements For more information about our social media principles, please visit https://www.leo-pharma.com/social-media-principles
Show all 7 entries ↓
Investment activity
2017–2025 · 4 investments
20171201912024120251
Recent (last 2 years)Earlier